Introduction
Chilblain lupus is a rare form of chronic cutaneous lupus erythematosus characterized by tender, bluish red swellings and nodules on acral surfaces such as the fin-TREX1 gene has been described in a pedigree of Bangladeshi origin [8] . During caspase-independent apoptosis initiated by granzyme A, TREX1 translocates into the nucleus and causes single-stranded DNA (ssDNA) damage by removing nucleotides from nicked 3´-ends, thus reducing the possibility of repair by rejoining the nicked ends [9] .
Mutations in TREX1 have been associated with a range of disorders with varying degrees of phenotypic overlap. These include Aicardi-Goutières syndrome, a rare infantile encephalopathy mimicking congenital viral infection characterized by basal ganglion calcification and chilblainlike lesions [10, 11] , autosomal dominant retinal vasculopathy with cerebral leukodystrophy [12] as well as systemic lupus erythematosus (SLE) [13] . While the molecular mechanisms underlying the diverse phenotypic spectrum of TREX1 mutations are not fully understood, functional analysis suggests a loss-of-function mechanism consistent with haplo-insufficiency [7, 10] . In this report we provide a detailed description of the clinical course of a severely affected member from the German pedigree with familial chilblain lupus, in which this novel genodermatosis was originally described [6] .
Case Report
The patient presented at 2 years of age with painful bluish red infiltrates on her fingers which were precipitated by sudden temperature changes during the cold season. The cutaneous lesions resembled those seen in her mother and brother, who both experienced similar recurrent skin changes confined to fingers and toes since early childhood. At the age of 9 years, she was admitted to the hospital for the first time because of worsened skin lesions after swimming lessons at school. At this time her fingers and the rims of her soles were affected by tender plaquelike lividoid infiltrates. Apart from skin findings, her physical examination was unremarkable. Laboratory investigations revealed the presence of antinuclear antibodies with a titre of 1: 160 and a homogeneous pattern, reduced levels of complement C4 (0.18 g/l, normal range 0.2-0.49) and the presence of C3d-binding immune complexes. Anticardiolipin IgG and IgM as well as serum IgA and IgG were slightly elevated. There was no serological evidence for viral or bacterial infections. Tests for cryoglobulins and cryofibrinogen were negative, and all other laboratory values including complete blood cell count with differential, coagulation and liver function tests as well as urine analysis were within normal ranges. Nailfold capillary microscopy showed no pathological findings. Although a skin biopsy was not performed at that time, the diagnosis of cutaneous lupus erythematosus was suspected. Under stringent cold protection and skin care with urea-containing ointments, the patient experienced improvement of skin symptoms during the following years until the age of 16, when she was hospitalized for anorexia and again suffered from a severe attack of erythematous skin lesions on fingers and toes.
At 18 years of age, she was referred to the hospital during late spring with bluish red infiltrates on erythematous skin partially covered with fine scales on the dorsal sides of fingers and toes ( fig. 1 ). The fingernails were thickened with areas of yellow brownish discolouration and peripheral onycholysis. In addition, multiple tender subcutaneous erythematous infiltrates without epidermal alteration were seen on the thighs, buttocks, knees as well as on the left cheek ( fig. 1 ). The lesions on the thighs were up to 4 cm in diameter and presented as deep, palpable infiltrations with a dark red to purple colour. Her complaints had increased during the last 4 164 months during which she was under mental stress due to her final examinations at school. She did not complain of painful joints or tendons, palpitations, mental changes, hair loss, light sensitivity, oral ulcerations or gastro-intestinal problems typically seen in SLE.
Her body mass index was 17.9 (normal range: 18.4-25.2), and her blood pressure was 90 over 40 mm Hg. Apart from bradycardia with a heart rate of 44/min, ECG, echocardiography and abdominal ultrasound were without any pathological findings.
Histological examination of lesional skin from the finger showed a partially atrophic epidermis with vacuolar degeneration of basal keratinocytes ( fig. 2 a) . Throughout the dermis, the vessel walls appeared swollen, and perivascular lymphocytic infiltrations with hydropic degeneration of the epidermal junction zone were seen. Alcian blue staining revealed marked deposition of mucin within the dermis. Epidermal findings in lesional skin from the thigh were rather discrete and included focal parakeratosis as well as follicular hyperkeratosis, while dermal changes were much more pronounced. Throughout the dermis extending to the upper subcutis, swollen vessel walls were surrounded by perivascular and periadnexal oedema as well as marked lymphocytic infiltrations ( fig. 2 b) . Prominent deposits of mucin were present throughout the entire dermis and parts of the subcutis ( fig. 2 c) . Direct immunofluorescence revealed band-like IgM and C3 depositions along the basement membrane zone on lesional skin from the finger and dorsal thigh ( fig. 3 a, b) . Together, the histological findings were consistent with cutaneous lupus erythematosus of the fingers and plaque-like mucinosis of the thigh.
Laboratory examinations showed reduction of erythrocyte count of 3. Indirect immunofluorescence of Hep-2 cells using the patient's serum showed a markedly elevated antinuclear antibody titre of 1: 1,000 with homogeneous staining of nucleoplasma and chromosomes ( fig. 3 c, d ). Auto-antibodies against Ro, La, nucleosomes, histones and doublestranded DNA were undetectable. However, auto-antibodies against ssDNA were weakly positive with 27 IU/ml ( ! 25 negative; 25-35 weakly positive, 1 35 IU/ml positive). Interferon -␣ levels in serum were not increased. Nailfold capillary microscopy showed reduced capillary density with shape deformities such as elongation, partial grouping and dilatation on all fingers.
Based on the clinical, serological and histological findings, the diagnosis of chilblain lupus following the criteria of Su et al. [2] was confirmed. At this time several members of her family including her brother and mother had been diagnosed as having autosomal dominant familial chilblain lupus caused by a heterozygous mutation in the TREX1 gene. This mutation could also be confirmed in the case of the patient. Immunofluorescence staining of TREX1 of lesional skin revealed high expression of TREX1 in keratinocytes, endothelial and mononuclear cells. In comparison to normal skin, a slightly higher expression of TREX1 within the cytoplasm of keratinocytes was noted ( fig. 4 ) .
The patient had been on a low dose of 100 mg acetylsalicylic acid (ASA) daily for the past 3 months prior to admission without clinical improvement. Due to her low blood pressure, therapy with the vasodilatory calcium channel blocker nifedipine was not considered initially. Instead, therapy with topical steroids and hydroxychloroquine at a low dose of 200 mg daily was started. In addition, the patient was in- structed to prevent exposure to cold. Therapy was well tolerated, and after 4 months of treatment the clinical manifestations on her hands, feet and thighs had markedly improved. During the cold winter season, amlodipine 5 mg daily was added to her medication. The drug was well tolerated and improved peripheral circulation. The cold-induced lesions appeared less lividoid, and heatable finger gloves prevented cold-induced ulcerations.
Discussion
The clinical presentation of this patient with chilblain lupus erythematosus is remarkable because of the extensive skin findings and the progressive course during adolescence, although the diagnostic criteria for SLE were formally never fulfilled. This is in contrast to the clinical presentation of other affected members of her family, in whom chilblain lesions tend to improve with age and progression to SLE has not been reported even in old age [6] . In addition to typical chilblain lesions in acral locations, the patient also presented with erythematous subcutaneous mucin-rich infiltrates without epidermal involvement on the thighs and the buttocks. This is reminiscent of LE tumidus lesions which are, however, usually smaller in size and located in sun-exposed areas [1] . Strong mucin deposition in nodular or papular form is rarely seen in discoid lupus erythematosus and occurs more frequently in patients with SLE accounting for about 2% of these cases [14, 15] . In addition, Jessner's lymphocytic infiltration of the skin has been recognized as a cutaneous form of lupus erythematosus that does not show epidermal involvement [16, 17] .
The early onset of the disease can be explained by the genetic defect in the TREX1 gene identified in this family, although the exact molecular mechanisms that lead to chilblain lupus remain not fully understood. This mutation [c.52G ] A, leading to the substitution of an aspartate with an asparagine at position 18 of the TREX1 peptide (D18N)] affects a highly conserved residue within the catalytic centre of the TREX1 enzyme and has been shown to impair DNA damage during granzyme-A-mediated apoptosis [6, 7] . Thus, this defect may be responsible for improper clearance of altered DNA causing intracellular accumulation of ssDNA, which in turn induces -through yet unidentified intracellular sensors and signalling pathways -an immune-mediated inflammatory response [7] . This is consistent with our finding of a strong expression of TREX1 in keratinocytes and vascular cells of the skin, the site of inflammation. Moreover, recent evidence suggests that intracellular accumulation of ssDNA in TREX1-deficient cells may be due to defects in the degradation of nucleic acids derived from chronic cell cycle checkpoint activation or from endogenous retroviruses [18, 19] . This notion is supported by the finding of auto-antibodies against ssDNA in the patient's serum, albeit at low levels, which suggest an auto-immune response to ssDNA. In view of the fact that heterozygous carriers of TREX1 variants have a high risk for developing SLE [13] , these findings underpin the importance of defects in intracellular nucleic acid metabolism for the pathogenesis of lupus erythematosus.
It is possible that additional permissive factors contributed to the clinical course in this patient. Thus, a low body mass index as well as pathological capillary changes observed in this patient may have played a role during exacerbation of chilblain lupus [20] . In fact, precipitation of chilblain lupus by anorexia in an adolescent male has recently been reported [21] . Because of the strong linkage disequilibrium of the HLA allele HLADRB10301 (HLA-DR3) and the C4 null allele, it is also possible that the low C4 levels in this patient are genetically determined [22] . C4 plays a critical role in the processing of immune complexes, and deficiency of C4 is known to confer susceptibility to SLE [23, 24] .
The therapy of chilblain lupus primarily includes protection from cold [25] and improvement of the peripheral blood flow with ASA or nifedipine [20, 26] . Topical steroids may be of benefit in some patients [27] . Hydroxychloroquine has been used with inconsistent success [3] and usually requires continued treatment throughout the warm season [2, 27] . The therapeutic effect of other immunosuppressive drugs such as cyclophosphamide or mycophenolate mofetil has been reported in single cases only [21] . In the present case bloodflow-enhancing intervention with ASA was not helpful, while treatment with hydroxychloroquine was highly effective. Taken together, the present case provides a detailed description of the unusual clinical course of a patient with familial chilblain lupus due to a mutation in TREX1 by demonstrating a rather progressive course with extended dermatological findings. In addition, this case indicates that hydroxychloroquine may be an efficient therapeutic option for severe cases of familial chilblain lupus.
